Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

BISMUTH SUBSALICYLATE

Active
SPE2DP-26-T-4214Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Bismuth subsalicylate tablets are being procured under a military contract with each tablet containing 262 mg of active ingredient and 140 mg of calcium, formulated as sugar-free oral tablets. The unit of issue is a single package containing 48 individually sealed tablets, with a total shelf life of 36 months and a mandatory minimum of 31 months remaining at the time of receipt by the first government activity. Packaging must comply with commercial standards and the Medical Marking Standard No. 1A dated February 4, 2013, ensuring product integrity and proper identification. Containers must protect against damage and breakage, and shipping containers must be suitable for safe delivery via common carrier at the lowest cost to the designated destination. The product is subject to strict temperature controls, avoiding exposure above 104°F or 40°C. The NSN is 6505012448010, with a procurement quantity of one package, delivery required within 20 days FOB destination, and no variance allowed in quantity. Inspection and acceptance occur at the destination. The contract is issued under Solicitation SPE2DP-26-T-4214, with a response deadline of July 27, 2026, and performance will be delivered to Fort Campbell, Kentucky. The supplier must be registered under either P/N NDC01490-0326-42 or NDC37000-0477-10, and all labeling, marking, and packaging must adhere to applicable DLA and DoD standards, including compliance with the DLA Master List of Technical and Quality Requirements incorporated by reference.

General Info

Bismuth subsalicylate tablets, 262 mg active, 140 mg calcium, 48-count sugar-free packs, 36-month shelf life, FOB Fort Campbell, NSN 6505012448010.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

BLDG 2434, FORT CAMPBELL, KY, 42223-1498, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Shairy M. Cartagena
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
BISMUTH SUBSALICYLATE TABLETS
BISMUTH SUBSALICYLATE TABLETS
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
OVER THE COUNTER, SUGAR FREE
.
EACH TABLET CONTAINS 262 MG OF
BISMUTH SUBSALICYLATE AND
140 MG OF CALCIUM
.
UNIT OF ISSUE IS A PACKAGE CONTAINING
48 INDIVIDUALLY SEALED TABLETS.
.
TOTAL SHELF LIFE IS 36 MONTHS.
.
THERE SHALL BE A MINIMUM OF 31 MONTHS
OF REMAINING SHELF LIFE AT THE TIME OF
RECIPT BY THE FIRST GOVERNMENT ACTIVITY.
.
AVOID EXCESSIVE HEAT (OVER 104°F OR 40°C)
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013
.
5/4/2015
1 PG = 48 TT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
SPE2DP-26-T-4214
SECTION B
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
THE PROCTER & GAMBLE DISTRIBUTING LLC 74188 P/N NDC01490-0326-42 THE PROCTER & GAMBLE DISTRIBUTING LLC 74188 P/N NDC37000-0477-10
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017548724 0001 PG 1.000
NSN/MATERIAL:6505012448010
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-244-8010 Quantity: 1 PG Purchase Request: 7017548724QTY: 1 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride 0.9% Injection, USP, in 250 mL bags, is being procured under contract SPE2DP-26-T-4215 with a requirement for two packaging groups, each containing 24 bags, for a total of 48 units. The product must comply with the DLA Master List of Technical and Quality Requirements, including Medical Marking Standard No. 1, which replaces all prior references to MIL-STD-129, and all packaging must be commercial grade, sealed, and designed to protect against damage during transport. Each unit must be packed in suitable shipping containers that ensure safe delivery via common carrier to the designated destination at the lowest possible freight cost. The item is regulated by the FDA, and procurement requires confirmation through EBS referral to the product specialist, including manufacturer and part number details. The product has a fixed 24-month shelf life with no extensions allowed, and must be stored at room temperature (25°C), with brief exposure to temperatures up to 40°C permitted without degradation. Approved manufacturers include B. Braun Medical Inc., ICU Medical, Inc., Cardinal Health 200, LLC, Owens & Minor Distribution Inc., and Trillamed LLC, each with specified NDC and part numbers. Delivery is required FOB destination within 20 days, with no tolerance for quantity variance. Inspection and acceptance occur at the delivery point, and the item is identified by NSN 6505-01-331-8945 under a federal solicitation issued by the Department of Defense’s Medical Supply Chain PHARM FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
PENTOBARBITAL SODIUPentobarbital Sodium Injection, Veterinary, is a Schedule II controlled substance with high abuse potential, manufactured as a 250 mL vial containing six grains of sodium pentobarbital for euthanasia purposes. The product is regulated by the FDA and subject to stringent federal controls, requiring storage in a vault at room temperature due to its classification as a DEA C-II drug. It must be labeled and packaged in accordance with the latest Medical Marking Standard No. 1 and DLA Packaging Requirements, with no tolerance for quantity variance—exactly two units are contracted for delivery within 89 days FOB destination, inspected and accepted at the delivery point. The item carries a non-extendable 24-month shelf life and must comply with OSHA’s Hazard Communication Standard, including submission of approved Safety Data Sheets and GHS-compliant labels prior to contract award. Suppliers are required to ensure employee training on hazardous communication protocols under 29 C.F.R. 1910.1200 and must remove all government identification from non-accepted items. This procurement is governed under solicitation SPE2DP-26-T-4219, with primary point of contact at the Department of Defense’s Medical Supply Chain, and delivery addressed to APO 96260-5479.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
PERMETHRIN CREAM RINSEPermethrin Cream Rinse is a 1% w/v topical pharmaceutical product supplied in plastic squeeze bottles containing 2 fluid ounces, each accompanied by a comb for application. The item is regulated by the FDA and must be received with a minimum of 21 months of remaining shelf life from the date of delivery, with a total shelf life of 24 months. Packaging must comply with commercial standards and medical marking standard No. 1, superseding all prior references to MIL-STD-129, ensuring protection against damage and safe transport via common carriers. Each unit must be sealed in an appropriate container and packed in suitable shipping containers to guarantee secure delivery to the designated FPO address. The product is classified as a hazardous material, requiring submission of current Safety Data Sheets (SDS) consistent with OSHA’s revised Hazard Communication Standard, which replaced MSDS requirements as of June 1, 2015. SDS must be provided to the contracting officer for approval prior to award and must accompany each shipment. Labels must conform to GHS and relevant federal regulations under 29 C.F.R. 1910.1200. Packaging must meet 49 CFR and ICAO standards for hazardous materials transport. The item is identified by NSN 6505-01-256-4972, with a purchase request of 2 units and a delivery deadline of 20 days after order award. Technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with applicable references RA001, RP001, and RQ001, and the procurement is issued under solicitation SPE2DP-26-T-4223 by the Department of Defense’s Medical Supply Chain PHARM FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride Injection 0.9% in 100 mL fill plastic containers, packaged in lots of 64 units per purchase group, is being procured under contract SPE2DP-26-T-4218 with a delivery requirement of 20 days FOB destination. The item is manufactured by B. Braun Medical Inc. with NDC 00264-1800-32 and part number S8004-5264, and is identified by NSN 6505-01-330-8924. The product has a non-extendable shelf life of 15 months and must be stored at room temperature, avoiding excessive heat. All packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must include the NSN, manufacturer, Cage code, date of manufacture, expiration or retest date, contract number, and lot number. Each unit must be sealed in a protective container, and shipments must use commercial exterior packaging suitable for safe transport by common carrier at the lowest cost. The contract specifies zero variance in quantity and requires inspection and acceptance at the destination. This is a regulated medical product under FDA oversight, and the contracting official must submit a referral in EBS for confirmation prior to award. The solicitation was posted on July 21, 2026, with a response deadline of July 27, 2026, and performance is directed to Fort Campbell, 42223-5000.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
TEST STRIPS AND COLOR
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
BUPIVACAINE AND EPINEP
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
Manufacturer of Lidocaine Hydrochloride (Source-Level Supply)The contract awards the manufacturing of Lidocaine Hydrochloride to meet the precise military specifications outlined under NSN 6505015865691, ensuring the product aligns with strict defense quality and safety standards. The manufacturer is required to comply with all relevant regulatory frameworks, conduct rigorous batch-level testing, and maintain readiness to support the defense supply chain with consistent, reliable deliveries. Production must adhere to current Good Manufacturing Practices and be fully traceable to meet federal procurement and inventory requirements. This is a subcontract under the auspices of the Defense Logistics Agency within the Department of Defense, classified under NAICS code 325412 for pharmaceutical and medicinal chemical manufacturing. The contract is positioned as a source-level supply arrangement, indicating the selected manufacturer will serve as a primary or sole provider for this critical medical compound used in military medical operations. While specific performance locations and point of contact details are not provided, the contract’s public link indicates active management through DLA’s procurement systems, and the posted date suggests preparation for fulfillment beginning in 2026.
Defense Logistics Agency

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 325412
New
DIBBS
Pharmaceutical Supply – Lidocaine HydrochlorideThe contract entails the supply of 1,000 pounds of Lidocaine Hydrochloride identified by NSN 6505015865691, adhering strictly to federal and Department of Defense procurement standards. The product must be fully traceable throughout the supply chain, with precise packaging and labeling that complies with all regulatory requirements to ensure safety, accountability, and readiness for military medical use. This is a subcontract under the broader procurement framework managed by the Defense Logistics Agency, part of the Department of Defense, and is classified under NAICS code 325412, which pertains to pharmaceutical and medicinal product manufacturing. The contract was posted on July 20, 2026, and is administered through DLA’s systems, with performance and delivery oversight coordinated through the designated DLA procurement channel. All deliverables must meet rigorous quality and documentation benchmarks to support the DoD’s medical logistics requirements.
Defense Logistics Agency

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 325412
New
DIBBS
Pharmaceutical Supply – Fluconazole TabletsThe Defense Logistics Agency, under the Department of Defense, has entered into a subcontract for the supply of Fluconazole Tablets, 150 mg, with NDC 00093-0880-55, manufactured by TEVA. The contract includes full packaging, labeling, and delivery of the medication to Fort Bragg, North Carolina, ensuring compliance with all federal pharmaceutical standards and military health system requirements. The NAICS code 325412 confirms the contract pertains to pharmaceutical and medicine manufacturing, and the performance location is specifically designated for military medical facility use. The award is structured as a subcontract under the broader DLA procurement framework and is set for execution with an initial posting date of July 20, 2026. Although no solicitation number or set-aside type is provided, the contract remains bound to federal acquisition regulations governing defense medical supply chains. Delivery logistics and product integrity are critical components, with all units required to meet strict quality and traceability specifications prior to arrival at the designated military installation. The contract’s UI link provides access to official documentation for tracking and verification purposes.
Defense Logistics Agency

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 325412
New
DIBBS
Pharmaceutical Supply – Guaifenesin Extended-Release TabletsThe contract specifies the supply and delivery of two boxes of Guaifenesin Extended-Release 600 mg tablets under the medical procurement standards of the Department of Defense. The items are intended to meet stringent regulatory and quality requirements mandated for military medical use, ensuring consistency, safety, and efficacy within the DoD healthcare system. This subcontract is administered by the Defense Logistics Agency and falls under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. The contract was posted on July 20, 2026, and is linked to a specific award and delivery identification through DIBBS, indicating it is part of an active procurement cycle. While details such as the place of performance and point of contact are not provided, the contract's structure suggests it is a streamlined fulfillment effort supporting routine medical inventory needs across DoD facilities. Compliance with federal procurement protocols and adherence to pharmaceutical standards are central to executing this obligation.
Defense Logistics Agency

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 325412
New
DIBBS
Pharmaceutical Supply – Lidocaine HydrochlorideThe contract entails the supply of Lidocaine Hydrochloride under strict compliance with FDA regulations, current Good Manufacturing Practices, and federal acquisition guidelines for commercial items. The product must be delivered by July 20, 2026, with terms specifying FOB Destination, meaning the seller assumes all transportation costs and risks until the goods reach the designated delivery point. The subcontract is issued by the Defense Logistics Agency under the Department of Defense, with the NAICS code 325412 indicating pharmaceutical preparation manufacturing. All aspects of production, packaging, and delivery must meet federal standards for quality, safety, and traceability, ensuring the product is suitable for government use. The contract is publicly accessible via the DIBBS platform under the referenced award and delivery numbers.
Defense Logistics Agency

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 325412
New
DIBBS
Medical Product Packaging and MarkingThe contract entails the packaging and labeling of pharmaceutical products to comply with Defense Logistics Agency traceability standards, requiring the inclusion of National Stock Number, Commercial and Government Entity code, Transportation Control Number, and manufacturer-specific identifiers. All work must meet stringent military logistics requirements to ensure accurate tracking and inventory management across the Department of Defense supply chain. The contract is structured as a subcontract under NAICS code 325412, which corresponds to pharmaceutical and medicinal product manufacturing, and is administered by the Defense Logistics Agency under the Department of Defense. The award reference is linked to contract SPE2DX25D9900 with delivery order SPE2DP26F7785, and the posting date indicates the opportunity was made available in July 2026. Performance location details are not specified, and no set-aside status or point of contact information is provided.
Defense Logistics Agency

POSTED

1 day ago

DEADLINE

N/A
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 423450
New
DIBBS
LIDOCAINE HYDROCHLOLidocaine Hydrochloride and Epinephrine, USP, is a parenteral injectable pharmaceutical product containing a 2 percent concentration of lidocaine hydrochloride and a 1:50,000 dilution of epinephrine bitartrate, supplied in 1.7 mL single-dose cartridges. The unit of issue is a package of 50 cartridges, each contained within cardboard boxes featuring five blisters of ten cartridges each. The product must be stored at controlled room temperature below 25°C (77°F), protected from light, and must not be frozen. It is regulated by the FDA and requires a prescription. The item has a non-extendable shelf life of 18 months and must be marked in full compliance with Medical Marking Standard No. 1, superseding all prior references to MIL-STD-129. Packaging and shipping must meet commercial standards, with each unit sealed and protected in suitable containers to ensure safe transport via common carrier, and all exterior containers must meet federal logistics requirements. The procurement is issued under contract SPE2DP-26-T-4213 with a solicitation posted on July 21, 2026, and responses due by July 27, 2026. The quantity required is one unit of issue (50 cartridges), with delivery required within five days of award to the destination at Joint Base Elmendorf-Richardson, Alaska. Delivery is FOB destination and subject to zero variance in quantity. Inspection and acceptance occur upon delivery. The item is classified under NSN 6505-01-576-2767, with procurement reference PR 7017548713. All technical and quality requirements referenced in the DLA Master List are incorporated by reference, and the product must be sourced from approved manufacturers including Dentsply Sirona Inc. with NDC 66312-0181-16. Government use requires adherence to all applicable defense logistics standards, including transport protocols and marking instructions, with a designated point of contact and official delivery address provided for coordination.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
PSYLLIUM HYDROPHILIC M
Medicinal and Botanical Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
VERAPAMIL HYDROCHLORID
Medicinal and Botanical Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATE
Medicinal and Botanical Manufacturing

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATIONThis contract specifies the procurement of a topical sunscreen preparation containing 4.5% titanium dioxide and 4% zinc oxide with a sun protection factor (SPF) of 50, formulated to be sweat- and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, biodegradable, and suitable for outdoor use. The product is packaged in units of 24 three-ounce tubes per package, with a total shelf life of 24 months, and requires a minimum of 21 months of remaining shelf life upon receipt by the first government activity. Storage must be maintained between 15°C and 30°C (59°F and 86°F) in a cool, dry environment. The item is classified as a FDA-regulated medical product and must comply with all applicable DLA Master List of Technical and Quality Requirements, including packaging standards under Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercially sealed to protect against damage, and exterior shipping containers must ensure safe delivery at the lowest freight cost to the designated destination. The unit of issue is a package (PG), with a total quantity of four packages to be delivered FOB destination within 20 days. Delivery is directed to USS CHARLESTON LCS 18 at FPO AP 96694 via vessel shipment, using the fastest traceable means and prohibiting parcel post. The item is identified by NSN 6505-01-657-9247 and procurement request 7017560985, with a required delivery date of July 23, 2026. All packaging and labeling must conform to the latest edition of Medical Marking Standard No. 1 and DLA packaging requirements, and the material must be non-hazardous under FED-STD-313, complying with ASTM D3951 unless superseded by a higher-priority DLA technical requirement. The solicitation is issued under contract SPE2DP-26-T-4222, and bidders must confirm product specifications with the DLA product specialist through EBS, providing full manufacturer and item detail.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 13 hours ago

DEADLINE

in 5 days
View Details
NAICS: 484220
New
DIBBS
Domestic and International Hazardous Materials Transportation CoordinationThe contract requires comprehensive coordination and management of hazardous medical materials transportation across domestic and international territories using air, ground, and sea modes, with strict adherence to federal and international regulations including 49 CFR, ICAO, IMDG, and DLAI 4145.3. A critical responsibility involves preparing accurate Shipper’s Declarations for military air shipments, ensuring all documentation meets stringent compliance standards for safety and legal requirements. The work is centered on maintaining seamless logistics while safeguarding personnel, infrastructure, and the environment throughout the transportation chain. Performance is mandated to occur in Groton, Connecticut, with a response deadline of July 27, 2026, and the contract is classified as a subcontract under NAICS code 484220. The awarding agency is the Department of Defense through the Medical Supply Chain Pharm FSA, indicating this effort supports critical military medical logistics operations. All activities must align with Defense Logistics Agency standards and ensure full traceability and regulatory control of hazardous shipments from origin to final destination.
Specialized Freight (except Used Goods) Trucking, Local

POSTED

1 day ago

DEADLINE

in 5 days
View Details
NAICS: 541620
New
DIBBS
Material Safety Data Sheet (MSDS) Management and DocumentationThe contract requires the preparation, updating, management, and submission of Material Safety Data Sheets for hazardous materials, ensuring strict adherence to OSHA, GHS, and DLA regulatory standards. All documentation must be maintained with a minimum three-year retention period to support compliance and audit readiness. The work is to be performed for the Department of Defense’s Medical Supply Chain Pharm FSA, with the place of performance located in Groton, Connecticut, at the zip code 06340-4905. This subcontract falls under NAICS code 541620, indicating it involves scientific and technical consulting services related to health and safety compliance. The solicitation was posted on July 20, 2026, with a response deadline of July 27, 2026, and additional information can be accessed through the DIBBS platform.
Environmental Consulting Services

POSTED

1 day ago

DEADLINE

in 5 days
View Details